Trahan Jeremy 4
Research Summary
AI-generated summary
Viemed (VMD) General Counsel Jeremy Trahan Receives Vesting Awards
What Happened
- Jeremy Trahan, General Counsel of Viemed Healthcare, had equity awards vest on January 29, 2026. A total of 10,774 Restricted Stock Units (RSUs) vested; 2,939 of those shares were withheld by the company to cover taxes (value of withheld shares based on the Jan 29 closing price of $7.48 = $21,984). In addition, 3,591 phantom share units vested and were cash‑settled — the underlying common shares were effectively acquired and immediately disposed to the company for cash proceeds of $26,861 (3,591 × $7.48).
- These transactions are awards/settlements (not open‑market purchases). Withholding of shares for tax and cash settlement of phantom units are routine administrative actions tied to vesting.
Key Details
- Transaction date: January 29, 2026; Form 4 filed February 2, 2026 (filed within the two‑business‑day reporting window).
- Per‑share price used for value calculations: $7.48 (closing market price on Jan 29, 2026).
- RSUs vested: 10,774 shares; shares withheld for taxes: 2,939 shares (≈ $21,984).
- Phantom units vested and cash‑settled: 3,591 units, cash proceeds ≈ $26,861.
- Shares owned after the transaction: Not specified in the provided filing excerpt.
- Notable footnotes: RSUs represent the right to one common share each (F1, F5); withheld shares satisfy tax obligations (F2); phantom shares are cash‑settled equivalents of common shares and were reported as simultaneous acquisition and disposition for cash (F4, F6).
Context
- This was vesting and settlement activity (awards converted/settled), not an indicator of an open‑market buy or sell decision. The phantom units were cash‑settled (effectively a payout), and some RSU shares were withheld to pay taxes — both are common administrative outcomes of awards vesting.